Bayer CropScience declared an FY27 interim dividend of ₹90 per share, while results for the quarter ended Sept. 30 showed higher profit and lower revenue than a year earlier.
The board set Thursday, Nov. 12, as the record date and scheduled payment for Nov. 30. Bayer will use its register on the record date to determine eligible shareholders. The company allocated ₹4.045 billion across 44,942,092 shares. The payment matches the ₹90-per-share interim dividend it declared for FY26.
The ₹90 payout is nine times the share’s ₹10 face value, or 900% of face value. That multiple describes the dividend against the share’s nominal value; it is not an investor’s return. Measured against the National Stock Exchange of India’s (NSE) closing price of ₹3,316.30 on Friday, Nov. 6, the payment was about 2.71% of the quoted price before tax. It compares one distribution with one closing price, not an annualized yield.
For the quarter, profit for the period was ₹1.662 billion, up from ₹1.527 billion a year earlier. Revenue from operations declined to ₹12.507 billion from ₹15.534 billion, while profit before tax reached ₹2.114 billion, compared with ₹2.003 billion. Deloitte Haskins & Sells LLP conducted a limited review of the unaudited results.
Simon Wiebusch, vice chairman, managing director and CEO, cited an uneven monsoon’s effect on sowing and demand for crop-protection products, along with lower corn acreage. Bayer said better margin performance, favorable yields in corn-seed production and cost efficiencies supported profit. Inventory rose as corn-seed output increased amid weaker demand. Chief Financial Officer Vinit Jindal said liquidity pressures delayed collections and left receivables marginally higher.
The filing identifies Agri Care as Bayer CropScience’s only reportable segment and says seasonal business patterns can limit what quarterly results show about the full year. The record date is Nov. 12, followed by the scheduled payment on Nov. 30.
